| Line item | 2025-07-31 FY | 2024-07-31 FY | 2023-07-31 FY | 2022-07-31 FY | 2021-07-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $160.00K | $177.00K | $169.00K | $159.00K | $158.00K |
| Operating Income | -$160.00K | -$59.00K | -$169.00K | -$159.00K | -$158.00K |
| Interest Expense | $62.00K | $54.00K | $30.00K | $14.00K | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$222.00K | -$113.00K | -$199.00K | -$173.00K | -$158.00K |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | – |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | – | – |
| Shares (diluted) | $154.81M | $154.81M | $154.81M | – | – |